Rubicon Research

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE506V01022
  • NSEID: RUBICON
  • BSEID: 544578
INR
1,719.35
-6.65 (-0.39%)
BSENSE

Nov 20

BSE+NSE Vol: 2.58 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.58 lacs (38.04%) Volume

Shareholding (Sep 2026)

FII

9.01%

Held by 70 FIIs

DII

15.73%

Held by 20 DIIs

Promoter

51.25%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a growth in Net Profit of 67.93%, the company declared Very Positive results in Sep 26

  • The company has declared positive results for the last 3 consecutive quarters
  • NET SALES(Q) Highest at Rs 576.38 cr
  • PBDIT(Q) Highest at Rs 144.08 cr.
  • PBT LESS OI(Q) Highest at Rs 114.63 cr.
2

Stock is technically in a Mildly Bullish range

3

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 28,100 Cr (Small Cap)

stock-summary
P/E

88.00

stock-summary
Industry P/E

40

stock-summary
Dividend Yield

0.09%

stock-summary
Debt Equity

0.15

stock-summary
Return on Equity

22.94%

stock-summary
Price to Book

20.21

Revenue and Profits:
Net Sales:
576 Cr
(Quarterly Results - Sep 2026)
Net Profit:
90 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.09%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.43%
0%
-2.43%
6 Months
74.54%
0%
74.54%
1 Year
147.34%
0%
147.34%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Rubicon Research for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News

Rubicon Research Gains 3.02% Despite Intraday Pressure: 2 Key Factors Driving the Week

Announcements stock-summary

Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) W.R.T Update On The Scheme Of Merger Between Rubicon Research Ltd And KIA Health Tech Pvt Ltd.

14-Nov-2026 | Source : BSE

Disclosure under Regulation 30 of SEBI LODR Regulations 2015 (SEBI Regulations) w.r.t update on the Scheme of Merger between Rubicon Research Ltd and KIA Health Tech Pvt Ltd

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

12-Nov-2026 | Source : BSE

Transcript of Earnings Call -Q2 - FY 2026-27

Announcement under Regulation 30 (LODR)-Newspaper Publication

06-Nov-2026 | Source : BSE

Newspaper Publication for Q2 ended September 30 2026 Financial Results

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Rubicon Research Ltd has declared 150% dividend, ex-date: 07 Aug 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
43.30%
EBIT Growth (5y)
75.22%
EBIT to Interest (avg)
8.72
Debt to EBITDA (avg)
1.44
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
1.10
Tax Ratio
22.03%
Dividend Payout Ratio
0.23%
Pledged Shares
0
Institutional Holding
24.73%
ROCE (avg)
24.61%
ROE (avg)
22.94%
Valuation key factors
Factor
Value
P/E Ratio
88
Industry P/E
40
Price to Book Value
20.12
EV to EBIT
64.82
EV to EBITDA
57.43
EV to Capital Employed
17.56
EV to Sales
13.67
PEG Ratio
NA
Dividend Yield
0.09%
ROCE (Latest)
27.10%
ROE (Latest)
22.94%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
Bollinger Bands
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 20 Schemes (13.78%)

FIIs

Held by 70 FIIs (9.01%)

Promoter with highest holding

General Atlantic Singapore Rr Pte Ltd (27.34%)

Highest Public shareholder

Shivanand Shankar Mankekar Huf (13.51%)

Individual Investors Holdings

3.89%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2026 is 7.87% vs 3.97% in Jun 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2026 is 6.72% vs 10.41% in Jun 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'26",
        "Jun'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "576.38",
          "val2": "534.34",
          "chgp": "7.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "144.08",
          "val2": "129.12",
          "chgp": "11.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "11.41",
          "val2": "9.29",
          "chgp": "22.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "90.48",
          "val2": "84.78",
          "chgp": "6.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.00%",
          "val2": "24.16%",
          "chgp": "0.84%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Rubicon Research"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Rubicon Research"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 36.57% vs 50.40% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 83.64% vs 47.63% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,753.96",
          "val2": "1,284.27",
          "chgp": "36.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "400.24",
          "val2": "264.26",
          "chgp": "51.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "42.17",
          "val2": "36.78",
          "chgp": "14.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "246.74",
          "val2": "134.36",
          "chgp": "83.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.82%",
          "val2": "20.58%",
          "chgp": "2.24%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Sep'26 - QoQstock-summary
Sep'26
Jun'26
Change(%)
Net Sales
576.38
534.34
7.87%
Operating Profit (PBDIT) excl Other Income
144.08
129.12
11.59%
Interest
11.41
9.29
22.82%
Exceptional Items
0.00
0.00
Consolidate Net Profit
90.48
84.78
6.72%
Operating Profit Margin (Excl OI)
25.00%
24.16%
0.84%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2026 is 7.87% vs 3.97% in Jun 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Sep 2026 is 6.72% vs 10.41% in Jun 2026

Annual Results Snapshot (Consolidated) - Mar'26stock-summary
Mar'26
Mar'25
Change(%)
Net Sales
1,753.96
1,284.27
36.57%
Operating Profit (PBDIT) excl Other Income
400.24
264.26
51.46%
Interest
42.17
36.78
14.65%
Exceptional Items
0.00
0.00
Consolidate Net Profit
246.74
134.36
83.64%
Operating Profit Margin (Excl OI)
22.82%
20.58%
2.24%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 36.57% vs 50.40% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 83.64% vs 47.63% in Mar 2025

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details